Apretude is the first and only long-acting, injectable PrEP

Pre-exposure prophylaxis (PrEP) reduces the risk of getting HIV from sex by about 99% and from injecting drugs by at least 74% when taken as prescribed. PrEP can be pills or shots. Truvada and Descovy are the two pills approved for use as PrEP. Cabotegravir (CAB) 600 mg (brand name Apretude) is the only approved injectable PrEP. Apretude is the first and only long-acting, injectable PrEP for reducing the risk of getting HIV. See the Figure below. Injectable PrEP with Apretude is highly effective at protecting patients from HIV and is for adults and adolescents who weigh at least 35 kg (77 lb) and are at risk of getting HIV through sex. Apretude is administered as an intramuscular injection every two months after two initiation injections administered one month apart. Before receiving Apretude, to reduce your risk of getting HIV-1, you must be HIV-1 negative to start Apretude. Do not receive Apretude unless you are tested and confirmed to be HIV-1 negative. Apretude is a good option for PrEP for people who have problems taking oral PrEP as prescribed, prefer getting a shot every two months instead of taking oral PrEP, and people who have serious kidney disease that prevents the use of oral PrEP medications. Apretude is highly effective at protecting people from HIV. Protect yourself from HIV. IPH is located at 9053 Woodward Ave, Detroit, Monday to Friday, 8:30 AM to 4:00 PM. Call 313-309-9350 ext. 2 for more information on HIV testing, PrEP, PEP, and treatment.